ProPhase Labs, Inc. Accrued Income Taxes
ProPhase Labs, Inc. (PRPH) had Accrued Income Taxes of $1.31 million as of 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:AccruedIncomeTaxes · last filed 2022-03-31
- 2021-12-31: Accrued Income Taxes $1.31M.
- 2021-06-30: Accrued Income Taxes $8.00K.
- 2021-03-31: Accrued Income Taxes $8.00K.
- 2020-12-31: Accrued Income Taxes $8.00K.
| Period end | Accrued Income Taxes |
|---|---|
| 2021-12-31 | $1.31M 10-K · filed 2022-03-31 |
| 2021-06-30 | $8.00K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $8.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $8.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |